On Wednesday, November 9, investors will grapple with the aftermath of Tuesday's presidential election, while parsing various earnings reports. Mylan (MYL) reports quarterly results after the markets close. Analysts expect earnings of $1.45 a share on sales of $3.12 billion. During the same quarter a year ago, the drug maker reported earnings of $1.43 a share on sales of $2.71 billion. Mylan is the maker of the EpiPen, which came into the spotlight back in August after announcing a 700% price hike for the lifesaving drug. Other notable quarterly reports include Shake Shack (SHAK) , Viacom (VIA) and DISH Network (DISH) . Federal Reserve officials Neel Kashkari and John Williams are expected to deliver remarks at various events on Wednesday. TheStreet's Scott Gamm reports from Wall Street.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.